X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2007) 2007
Publication (62) 62
Newsletter (21) 21
Book Review (20) 20
Magazine Article (7) 7
Newspaper Article (4) 4
Book Chapter (3) 3
Book / eBook (1) 1
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (1815) 1815
humans (1652) 1652
norethindrone - administration & dosage (1174) 1174
adult (833) 833
norethindrone - analogs & derivatives (629) 629
middle aged (613) 613
norethindrone - pharmacology (552) 552
obstetrics & gynecology (485) 485
estradiol - administration & dosage (414) 414
norethindrone - adverse effects (356) 356
animals (355) 355
time factors (301) 301
norethindrone - therapeutic use (286) 286
pregnancy (269) 269
ethinyl estradiol - administration & dosage (244) 244
norethindrone (240) 240
administration, oral (236) 236
adolescent (233) 233
norethindrone acetate (214) 214
drug combinations (211) 211
estrogen replacement therapy (202) 202
index medicus (199) 199
hormone replacement therapy (188) 188
menopause (188) 188
male (186) 186
estrogen (185) 185
rats (182) 182
estradiol (179) 179
double-blind method (177) 177
aged (175) 175
drug therapy, combination (174) 174
postmenopausal women (168) 168
prospective studies (155) 155
women (153) 153
norethindrone - blood (149) 149
postmenopause (148) 148
dose-response relationship, drug (146) 146
estradiol - blood (146) 146
drug administration schedule (145) 145
estradiol - pharmacology (141) 141
ethinyl estradiol - pharmacology (140) 140
endocrinology & metabolism (133) 133
administration, cutaneous (132) 132
contraceptives, oral, combined - administration & dosage (129) 129
estradiol - therapeutic use (127) 127
medroxyprogesterone acetate (123) 123
ethinyl estradiol (122) 122
contraceptive agents, female - administration & dosage (121) 121
injections, intramuscular (117) 117
estradiol - adverse effects (113) 113
treatment outcome (110) 110
endometrium - drug effects (109) 109
medroxyprogesterone acetate - administration & dosage (106) 106
contraceptives, oral - pharmacology (104) 104
progesterone - blood (101) 101
luteinizing hormone - blood (100) 100
mestranol - administration & dosage (100) 100
risk (100) 100
delayed-action preparations (99) 99
estrogen replacement therapy - methods (99) 99
ethinyl estradiol - adverse effects (98) 98
follicle stimulating hormone - blood (95) 95
hormone therapy (95) 95
oral contraceptives (95) 95
progesterone congeners - administration & dosage (95) 95
ovulation - drug effects (94) 94
contraceptives, oral - administration & dosage (93) 93
menstruation - drug effects (93) 93
progestins - administration & dosage (93) 93
estrogens - administration & dosage (91) 91
mestranol - pharmacology (90) 90
norgestrel - administration & dosage (90) 90
contraceptives, oral, synthetic - administration & dosage (88) 88
levonorgestrel (88) 88
lipids - blood (88) 88
norethindrone - metabolism (86) 86
progesterone (85) 85
estradiol - analogs & derivatives (84) 84
cholesterol - blood (83) 83
medroxyprogesterone - administration & dosage (83) 83
norgestrel - pharmacology (83) 83
reproductive biology (83) 83
norethindrone - pharmacokinetics (79) 79
replacement therapy (78) 78
contraceptives, oral, combined - adverse effects (76) 76
estrogen replacement therapy - adverse effects (76) 76
contraception (75) 75
clinical trials as topic (74) 74
contraceptives, oral - adverse effects (72) 72
drug interactions (71) 71
norethisterone (71) 71
pharmacology & pharmacy (71) 71
contraceptives, oral, combined - pharmacology (70) 70
norethisterone acetate (70) 70
triglycerides - blood (70) 70
progestin (67) 67
risk factors (66) 66
contraceptive agents, female - adverse effects (65) 65
kinetics (64) 64
pharmacokinetics (63) 63
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1824) 1824
German (66) 66
French (33) 33
Russian (22) 22
Japanese (21) 21
Spanish (19) 19
Chinese (11) 11
Polish (9) 9
Czech (7) 7
Bulgarian (6) 6
Danish (5) 5
Italian (5) 5
Norwegian (3) 3
Portuguese (3) 3
Swedish (2) 2
Dutch (1) 1
Hungarian (1) 1
Romanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0182045
Combined estrogen-progestin preparations (CEPs) are associated with thromboembolic (TE) side effects. The aim of this study was to evaluate the incidence of TE... 
HORMONAL CONTRACEPTION | SYSTEM DATABASE | SIGNAL-DETECTION | VENOUS THROMBOEMBOLISM | MYOCARDIAL-INFARCTION | THROMBOSIS | ODDS RATIO | MULTIDISCIPLINARY SCIENCES | ORAL-CONTRACEPTIVE USE | SWEDISH WOMEN | RISK | Norgestrel - administration & dosage | Thromboembolism - chemically induced | Desogestrel - adverse effects | Humans | Middle Aged | Progestins - adverse effects | Male | Norgestrel - adverse effects | Estrogens - adverse effects | Norethindrone - administration & dosage | Young Adult | Ethinyl Estradiol - adverse effects | Drug-Related Side Effects and Adverse Reactions - genetics | Norethindrone - adverse effects | Adult | Female | Ethinyl Estradiol - administration & dosage | Contraceptives, Oral, Combined - administration & dosage | Odds Ratio | Child | Databases, Factual | Androstenes - adverse effects | Adverse Drug Reaction Reporting Systems | Japan | Androstenes - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Desogestrel - administration & dosage | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Progestins - administration & dosage | Adolescent | Estrogens - administration & dosage | Progestational hormones | Thromboembolism | Health aspects | Risk factors | Estrogen | Drugs | Ethinylestradiol | Medical equipment | Medical devices | Anemia | Estrogens | Cases (containers) | Risk analysis | Data mining | Patients | Estradiol | Data bases | Incidence | Birth control | Sex hormones | Side effects | Databases | Progestin | Health risk assessment | Pharmaceuticals
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2017, Volume 107, Issue 3, pp. 533 - 536
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2014, Volume 101, Issue 6, pp. 1565 - 1573.e18
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2013, Volume 71, Issue 1, pp. 193 - 202
Vismodegib, a first-in-class oral hedgehog pathway inhibitor, is an effective treatment for advanced basal cell carcinoma. Based on in vitro data, a clinical... 
Medicine & Public Health | Erivedge | Drug–drug interaction | Rosiglitazone | Oncology | Cancer Research | Oral contraceptive | Vismodegib | Pharmacology/Toxicology | Drug-drug interaction | SONIC HEDGEHOG | Erivedge (TM) | CANCER | GDC-0449 | METABOLISM | ONCOLOGY | MEDULLOBLASTOMAS | PHARMACOLOGY & PHARMACY | MUTATIONS | INHIBITOR | HUMAN HOMOLOG | HEDGEHOG SIGNALING PATHWAY | Cytochrome P-450 CYP2C8 | Ethinyl Estradiol - pharmacokinetics | Area Under Curve | Contraceptives, Oral, Combined - pharmacokinetics | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Anilides - pharmacokinetics | Antineoplastic Agents - administration & dosage | Norethindrone - administration & dosage | Thiazolidinediones - pharmacokinetics | Neoplasm Metastasis | Drug Interactions | Norethindrone - pharmacokinetics | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Ethinyl Estradiol - administration & dosage | Contraceptives, Oral, Combined - administration & dosage | Pyridines - administration & dosage | Aryl Hydrocarbon Hydroxylases - drug effects | Aryl Hydrocarbon Hydroxylases - metabolism | Neoplasms - drug therapy | Anilides - administration & dosage | Cytochrome P-450 CYP3A - metabolism | Anilides - pharmacology | Aged | Pyridines - pharmacology | Neoplasms - pathology | Cohort Studies | Complications and side effects | Analysis | Drug interactions | Cytochrome P-450 | Ethinyl estradiol | Metastasis | Oral contraceptives | Thiazolidinediones | Skin cancer | Index Medicus
Journal Article
AAPS PharmSciTech, ISSN 1530-9932, 2/2019, Volume 20, Issue 2, pp. 1 - 14
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 06/2018, Volume 58, Issue 6, pp. 781 - 789
It is known that a small fraction of orally administered norethisterone is metabolically converted to ethinylestradiol. This exploratory, open‐label,... 
hormone replacement therapy | norethisterone | thromboembolism | contraception | ethinylestradiol | NORETHINDRONE | ETHINYL ESTRADIOL | CONVERSION | PHARMACOLOGY & PHARMACY | POSTMENOPAUSAL WOMEN | ACETATE | Confidence intervals | Ethinylestradiol | Equivalence | Oral administration | Exposure | Dosage | Health risk assessment
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 10/2017, Volume 76, Issue 2, pp. e47 - e51
Journal Article